There are a number of researches on the healing power of ginger on Coronary Heart Disease (CHD).
One study investigates the power of ginger (and another substance called fenugreek) consumption on blood lipids, sugar blood content, and platelet aggregation in patients with Coronary Heart Disease (CHD). Individuals for this study are included from the category of healthy individuals, individuals with CHD, and patients with type 2 diabetes mellitus (T2DM) [Having CHD or not]. In CHD patients, Researchers have found that there is no effect on platelet aggregation, blood sugars and lipids when ginger was given at a dose of 4 g/day for 90 days. Nevertheless, when taken a single large dose of about 10 g of ginger, effective reductions in platelet aggregation were observed, shows that large doses are crucial for the maximum benefit.
Fenugreek had a significant influence on blood lipids which is mostly seen after 3 months in those patients with CHD and T2DM and also similar result is observed on blood sugar in those with DM. Ginger’s level of healing rate for minimizing blood pressure (BP) was tested under varied dosages. A dose-dependant of 0.3—3 mg/kg lowering was noted in arterial BP, which gives energy for ginger’s mission in BP regulation and control. An enzyme called Aldose Reductase plays insignificant role in healthy humans but this is a different story in diabetics. The reality is that the abnormal metabolic outputs of Aldose Reductase thought to be responsible for many diabetic cases.Since ginger has been known to have a minimum of 5 components working as aldose reductase inhibitors, ginger plays a significant role in the prevention of diabetes complications.
A ginger preparation was chosen to normal and cholesterol-fed male rats to observe weather blood lipids would decrease or not.Trikatu, was a potent hypo-lipidemic agent due to the natural ability to minimize triglycerides and LDL cholesterol and simultaneously to increase HDL.
For more information,visit Whatisaginger.com